Literature DB >> 6120393

Diazepam and the risk of breast cancer.

D W Kaufman, S Shapiro, D Slone, L Rosenberg, S P Helmrich, O S Miettinen, P D Stolley, M Levy, D Schottenfeld.   

Abstract

The relation of breast cancer to diazepam use was evaluated in a case-control study of 1236 women with breast cancer and 728 control subjects with other malignancies. Compared to women who never used diazepam, the relative risk for women who used the drug at least 4 days per week for at least 6 months was estimated to be 0.9, with 95% confidence limits of 0.5 and 1.6. There was no apparent association for recent use, or for use in the distant past, although confidence intervals were fairly wide in these categories. The results were not explained by various potential confounding factors, including the major risk factors for breast cancer. The findings suggest that regular diazepam use does not increase the risk of breast cancer relative to other cancers.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6120393     DOI: 10.1016/s0140-6736(82)92046-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Plasmid profile analysis in epidemiological studies of animal Salmonella typhimurium infection in Japan.

Authors:  M Nakamura; S Sato; T Ohya; S Suzuki; S Ikeda
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

Review 2.  Nonhormonal drugs and cancer.

Authors:  P D Stolley; S H Zahm
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

3.  Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies.

Authors:  Tao Zhang; Xiaowen Yang; Jianrui Zhou; Pei Liu; Hui Wang; Anrong Li; Yi Zhou
Journal:  Oncotarget       Date:  2017-10-19

4.  Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies.

Authors:  Tzu-Rong Peng; Li-Jou Yang; Ta-Wei Wu; You-Chen Chao
Journal:  Medicina (Kaunas)       Date:  2020-10-01       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.